Compared to other intracranial malignancies, PCNSL has some characteristic genetic features, such as MYD88 and CD79B mutations, and ctDNA may also play a role in the diagnosis and differential diagnosis of PCNSL (102). This evidence concerns the gene MYD88 and primary central nervous system lymphoma.